Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

Top 10 Oil-producing Countries (Updated 2024)

How to Invest in OpenAI's ChatGPT (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Hydrogen Stocks: 9 Biggest Companies in 2024

Where Does Tesla Get its Lithium? (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Trending Press Releases

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

Altech – CERENERGY® First 60 KWh Prototype Online and Achieving Great Results

In Search of Alternative Financing for Critical Minerals Projects

Glencore Loan Facility Closed, Offtakes Executed

SAGA Metals Engages Expert Geologist for Petrographic Analysis and Prepares for Second Tranche of IPO

More Press Releases
Trending Companies

Saga Metals

SAGA:CA

Sociedad Quimica y Minera S.A. (SQM)

SQM:NYE

Albemarle Corporation

ALB

Altech Batteries

ATC:AU
More Companies
Trending Reports

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

Rare Earths Outlook Report

2024 Energy Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Century Therapeutics Inc.

NASDAQ:IPSC
Press Releases

Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.

Interactive Chart

×